Terkko Navigator / International Journal of Cancer

Assessing Population Diversity in Phase III Trials of Cancer Drugs Supporting FDA Approval in Solid Tumors

Chronic viral hepatitis, HIV infection and Non‐Hodgkin Lymphomas in West Africa, a case‐control study

Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma

Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer

Oligometastatic breast cancer: Are we there yet?

Lymph node metastases in breast cancer: investigating associations with tumor characteristics, molecular subtypes, and polygenic risk score using a continuous growth model

Association of body composition with risk of overall and site‐specific cancers: A population‐based prospective cohort study

Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men

CTLA‐4 Antibody Aggrandizes Antitumor Immune Response of Oncolytic Virus M1 via Targeting Regulatory T Cells

Risk of breast cancer and prediagnostic urinary excretion of bisphenol A, triclosan and parabens: The Multiethnic Cohort Study

Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma

Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase‐related pathway are associated with non‐small cell lung cancer survival

Caspase‐8: A key protein of cross‐talk signal way in “PANoptosis” in cancer

A first‐in‐class, first‐in‐human, phase I trial of CIGB‐552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF‐κB in patients with advanced solid tumors

Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer.

The enduring need for prospective cohort studies to more completely characterize the tobacco‐caused burden of cancer

BiasCorrector: Fast and accurate correction of all types of experimental biases in quantitative DNA methylation data derived by different technologies

Identification of calmodulin‐like protein 5 as tumor‐suppressor gene silenced during early stage of carcinogenesis in squamous cell carcinoma of uterine cervix

Real‐world utilization of EGFR TKIs and prognostic factors for survival in EGFR‐mutated non‐small cell lung cancer patients with brain metastases

Clinicopathological factors associated with tumour‐specific mutation detection in plasma of patients with RAS‐mutated or BRAF‐mutated metastatic colorectal cancer

Causal Association of Childhood Obesity with Cancer Risk in Adulthood: A Mendelian Randomization Study

Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor‐ Findings from the ESCCAPE multi‐country case‐control studies

Exploring the interactions between Hp infection and other risk factors of gastric cancer: a pooled analysis in the Stomach cancer Pooling (StoP) Project

Umbilical metastases: real‐world data shows abysmal outcome

On The Mechanism Of Tumor Cell Entry Of Aloe‐Emodin, A Natural Compound Endowed With Anticancer Activity

Population‐based cancer staging for oesophageal, gastric, and pancreatic cancer 2012‐2014: International Cancer Benchmarking Partnership SurvMark‐2

Colorectal cancer incidence and mortality after negative fecal immunochemical tests by age 70: a prospective observational study

Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion

Transcription of Human Papillomaviruses in Non‐Melanoma Skin Cancers of the Immunosuppressed

Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations

Application of a classifier combining bronchial transcriptomics and chest CT features facilitates the diagnostic evaluation of lung cancer in smokers and non‐smokers

Pre‐ and post‐diagnosis leisure time physical activity and survival following diagnosis with ovarian cancer

International Trends in Incidence of Osteosarcoma (1988‐ 2012)

Trends in childhood cancer incidence in sub‐Saharan Africa: Results from 25 years of cancer registration in Harare (Zimbabwe) and Kyadondo (Uganda)

Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039

Differential genetic influences over colorectal cancer risk and gene expression in large bowel mucosa

The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non‐small cell lung cancer (ICBP SurvMark‐2 project)

Cell‐based Model Systems for Genome Instability: Dissecting the Mechanistic Basis of Chromothripsis in Cancer

Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the EPIC cohort

Cancer care in East Africa amidst the Covid‐19 pandemic

Feasibility of deep learning‐based fully automated classification of microsatellite instability in tissue slides of colorectal cancer

Fake data, paper mills, and their authors: The International Journal of Cancer reacts to this threat to scientific integrity

Cumulative COVID‐19 incidence, mortality and prognosis in cancer survivors: A population‐based study in Reggio Emilia, Northern Italy

Dietary inflammatory potential, oxidative balance score, and risk of breast cancer: Findings from the Sister Study

Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2‐negative metastatic breast cancer

Association of genomic variants at PAX8 and PBX2 with cervical cancer risk

Upfront transplantation may have better outcomes than pre‐transplant cytoreductive therapy for treating patients with MDS‐EB‐1 or MDS‐EB‐2

Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: a multinational cohort study

Red meat consumption, cooking mutagens, NAT1/2 genotypes and pancreatic cancer risk in two ethnically diverse prospective cohorts

COVID‐19 and cancer: A deadly pairing